Patient outcomes are taking over from products and services as the focus of healthcare. But reorienting away from product development toward a holistic approach to patients demands the convergence of data from every part of the healthcare system. In this interview, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving, Jared Josleyn, global head of corporate development at Alphabet-owned Verily Life Sciences, talks with McKinsey’s Michele Raviscioni about the need to integrate health data and apply it to patients’ lives in ways that achieve enduring impact.